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Abstract
Background: Intranodal palisaded myofibroblastoma is one of the primary mesenchymal tumours. The inguinal
region is the commonest site of this rare tumour. As there are only about 55 such cases reported in the literature,
the precise aetiology and pathogenesis have yet to be explained adequately. Here we report a case of a 72 year
old man presented with incidental finding of intranodal palisaded myofibroblastoma in the retroperitoneal region.
Case Presentation: A 72-year old man presented with abdominal pain in right upper quadrant with an incidental
finding of abdominal mass in the right flank. The computerised tomogram scan of abdomen confirmed acute
cholecystitis with a 5 x 5 cm retroperitoneal mass. He underwent cholecystectomy with excision of this mass. He
recovered well following his operation and was discharged from the hospital. Histological examination confirmed
the diagnosis of intranodal palisaded myofibroblastoma.
Conclusion: To our knowledge, this is the first case of intranodal palisaded myofibroblastoma originating from
retroperitoneum. Along with the rarity of this case, we also discussed its typical histopathological findings,
aetiology and pathogenesis.
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Background
In comparison to secondary mesenchymal tumours, pri-
mary mesenchymal tumours involving lymph nodes are
very rare. The most common primary mesenchymal
tumours include Kaposi’s sarcoma, pseudosarcomatous
malignant melanomas and melanocytic naevi [1]. Intra-
nodal palisaded myofibroblastoma (IPM), one of the
rare primary mesenchymal tumours, was first described
in English literature in 1968, though not classified as
Intranodal palisaded myofibroblastoma [2]. These
tumours arise from the lymph nodes and are almost
always seen in the inguinal lymph nodes, although few
cases of mediastinal and submandibular lymph node ori-
gins have also been reported [3]. Its unique microscopic,
macroscopic and immunohistochemical features differ-
entiate it from other mesenchymal tumours. IPM shows
both myofibroblastic and smooth muscle differentiation
with the formation of the “amianthoid fibres”.T od a t e
only about 55 cases of IPM have been reported in the
English literature [4-6]. In this case report we presented
another case of IPM, but originating from retroperito-
neum. To our knowledge, this origin of IPM has not yet
been reported. Apart from the rarity of this tumour, we
also discussed its characteristic features, aetiology and
pathogenesis.
Case Presentation
A 72 year-old man presented in the emergency depart-
ment with right upper quadrant and epigastric pain,
nausea and vomiting. On examination, the patient was
sweating and pale with a tender right upper quadrant. A
tender 5 × 5 cm
2 mass was also noted in the right flank.
The provisional diagnosis of acute cholecystitis with
incidental finding of abdominal mass was made and
further investigation in the form of computerised tomo-
graphy (CT) of his abdomen and pelvis was performed.
The scan confirmed the presence of 50 × 55 mm
2 mass
in the retroperitoneum on the right side of the urinary
bladder but separate from the small intestinal loops
without any evidence of local infiltration. The radiologi-
cal differential diagnosis included carcinoid lesion and
teratoma of a right undescended testis. However,
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any medium, provided the original work is properly cited.undescended testis was ruled out with a fully grown tes-
tis on the right side of the scrotum. The patient under-
went exploratory laparotomy, open cholecystectomy and
also excision of the pelvic mass. Intra-operatively, the
mass was found to be approximately 8 cms in size,
partly haemorrhagic and covered by peritoneum. It was
situated lateral to the right ureter and superior to the
right iliac vessels. This mass was excised en-block with-
out any intra-operative complications. The patient had
an uneventful post-operative recovery and was dis-
charged on the 10th post-operative day. Histological
diagnosis of intranodal palisaded myofibroblastoma was
confirmed. He did not reveal any signs of recurrence in
seven years of follow up. The histopathological findings
are described as follows.
Macroscopic characteristics
AS o l i dm a s sm e a s u r i n g8 0×8 0×5 0m m
3 with sur-
rounding attached fatty tissue measuring up to 100
mms in maximum dimension was noted. On slicing, a
well defined nodule with partially firm, white and solid
areas, alternating with haemorrhagic areas, was found.
At the periphery there was some calcification. The
microscopic study was performed on extensively
sampled solid and haemorrhagic areas including the
resection margins. The gall bladder was 105 mms with a
thick wall and a few tiny stones.
Microscopic description
This represented encapsulated, a well defined nodular
lesion with variable cellularity. The cells were spindle
shaped with slightly wavy nuclei forming short interla-
cing fascicles, exhibiting areas that were reminiscent of
AntonyA/Antony B area (figure 1). No significant
nuclear pleomorphism was visible however mitosis was
rarely noted in 1 in up to 30 high power field (× 40
objective). Areas of fresh as well as old haemorrhages
were present. At the periphery, reactive lymphoid infil-
trate and focal calcification were also noted (figure 2).
The tumour showed a prominent fascicular growth pat-
tern with many short and long interlacing fascicles of
tumour cells (figure 3). Amianthoid fibres were easily
identified though in few areas of the tumour (figure 4).
Immunohistochemical Staining
The spindle cells were positive for Smooth muscle actin
(SMA) (Figure 5), Calponin and Vimentin but did not
express Desmin and h-Caldesmon. The tumour cells
showed strong nuclear expression of Cyclin D1 (figure
6). The cells were negative for neurofilament, cytokera-
tin. The staining for S100 protein, CD34, CD99, Bcl-2
and CD117/C-kit were negative in the tumour cells.
Immunostaining for Alk-1 and HHV 8 were negative in
these cells (figure 7 & 8).
Conclusions
Among primary mesenchymal tumours, intranodal pali-
saded myofibroblastoma is very rare. It was initially
described by Deligdish and Katz as neurilemmoma or
schwanoma and later classified as palisaded myofibro-
blastoma by Weiss [7,8]. It shares many features of myo-
fibroblasts and smooth muscle cells microscopically as
well as immunohistochemically. This mesenchymal spin-
dle cell tumour arises from the lymph nodes. It is most
commonly seen in the inguinal lymph nodes, however
origins from submandibular and mediastinal lymph
nodes have also been reported [3].
IPM commonly affects the second to eighth decade,
with a peak incidence in the group between 40 and 60
years of age, but occurrence of this tumour in an infant
has also been reported [9,10]. It is more common in
men with a male to female ratio 1.5:1 and is not specific
Figure 1 High power view of the tumour with interlacing
fascicles of spindle cells. H & E × 10 objective.
Figure 2 Low power view of the tumour with the capsule and
lymphoid cell infiltrate at the periphery. H & E × 4 objective.
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tion is a painless slow growing lump in the inguinal
region. With increasing size discomfort, pain and com-
pression of local surrounding structures may manifest
various symptoms. It is most often diagnosed clinically
as lymphadenopathy and histological diagnosis is estab-
lished on excision biopsy. Fortunately, this tumour is
associated with very low recurrence rate and the recur-
rence is almost benign in nature. In a series of 30 cases,
only 6% was reported to demonstrate benign local
recurrence [12,13]. Creager et al reported only a single
case of intranodal palisaded myofibroblastoma with
metastatic bone formation [13].
It is essential to differentiate IPM from other soft tissue
tumours. These include Schwannoma, Kaposi’s sarcoma,
intranodal leiomyoma, inflammatory pseudotumour, soli-
tary fibromastocytic tumour, angiomyomatous hamartoma
and metastatic spindle cell lesions in the lymph node. The
clinical history, examination and typical histological char-
acteristics help in the correct diagnosis of the IPM.
Schwannoma is uncommon in the inguinal region and
immunohistochemically it is positive for S100 that differ-
entiates it from IPM. Negative immunostaining for HHV
8 along with an absence of EBV DNA and a history of
immunocompromised status favours the diagnosis of IPM
rather than Kaposi’s sarcoma. There were no slit-like vas-
cular channels, no extravasation of red blood cells and no
hyaline globules as typically seen in Kaposi’s sarcoma. Dif-
ferentiation of inflammatory myofibroblastic tumour
(IMT) from IPM can be made by the presence of inflam-
matory cells and absence of the amianthoid fibers in IMT
[14]. Negative immunostaining for Alk-1 and the presence
of amanthoid fibres with absence of inflammatory cell
infiltrate, including lymphocytes and plasma cells,
Figure 3 High power view of the tumour showing prominent
fascicular growth pattern with many short and long interlacing
fascicles. H & E × 20 objective.
Figure 4 High power view of the tumour showing amianthoid
fibres. H & E × 40 objective
Figure 5 High power view of the tumour showing strong
expression of smooth muscle marker, SMA. × 10 objective
Figure 6 High power view of the tumour cells showing strong
nuclear expression of Cycline D1. × 40 objective
Sagar et al. BMC Clinical Pathology 2011, 11:7
http://www.biomedcentral.com/1472-6890/11/7
Page 3 of 5favoured the diagnosis of IPM. Furthermore, spindle cell
melanoma can be differentiated from IPM by high prolif-
erative activity and marked cellular atypia. Spindle cell
melanoma is also positive for S100 and HMB-45 [15]. The
gastrointestinal stromal tumour is positive for CD117/C-
kit while IPM is negative. Regarding angiomyomatous
hamartomas in lymph nodes, the morphology and immu-
nostaining patterns are consistent with IPM rather than
angiomyomatous hamartomas.
Due to the rarity of the condition the precise aetiology
and pathogenesis have yet to be defined. Inguinal lymph
nodes have a higher concentration of myofibroblasts
compare to other lymph nodes in the body due to
increased drainage area and function: this might explain
its more common occurrence in the inguinal region.
This is favoured by positive staining for actin and vin-
mentin and negative for desmin in myofibroblasts of the
inguinal region compared to fibroblasts elsewhere in the
body [2]. However, its appearance in other parts of the
body contradicts this hypothesis. As in our case, the ori-
gin from the retroperitoneal region has not been
reported yet in literature and this again raises the ques-
tion of the aetiology of IPM.. The positive staining for
cyclin D1 suggests the possible role of the cell cycle reg-
ulatory genes in the pathogenesis of IPM [16]; thus
reporting of more number of cases is required to get a
better understanding of the aetiology and pathogenesis
of IPM.
Although rare, IPM should be considered as one of
the differential diagnosis in patients presenting with an
abdominal mass in the retroperitoneal region. This site
of origin may provide an opportunity to reconsider the
aetiology and pathogenesis of IPM.
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